1 / 11

R21 Malaria Vaccine

The WHOu2019s Global Technical Strategy for Malaria 2016u20132030 aims to reduce malaria case incidence and mortality rates by at least 40% by 2020, at least 75% by 2025, and at least 90% by 2030 against a 2015 baseline.

PlutusIAS
Download Presentation

R21 Malaria Vaccine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PLUTUS IAS

  2. Malaria Vaccine GS3: Science and Technology

  3. Malaria Vaccine • The subject of "Malaria Vaccine" is covered in this article's coverage of "Daily Current Affairs". The Science and Technology segment of the UPSC CSE test has applicability for this topic. Rishabh has researched and written the article. Additionally, our faculty has reviewed this article. Click the “ Malaria Vaccine” link to see the story's original version.

  4. R21/Matrix-M Malaria Vaccine: • Collaborative Effort: Developed through collaboration between the University of Oxford and the Serum Institute of India. • Adjuvant Technology: Utilizes Novavax's adjuvant technology. • WHO Recommendation: Received a WHO recommendation for usage due to compliance with safety, quality, and efficacy criteria. • Second Malaria Vaccine: Known as the Matrix-M malaria vaccine, it is the second vaccine ever developed for malaria.

  5. Malaria Burden Worldwide: • 2021 Statistics: 247 million malaria cases, slightly higher than 2020. • India Cases (2022): Reported over 45,000 cases. • Vulnerable Population: Approximately 80% of all malaria deaths in the WHO African Region affect children under five years of age.

  6. About Malaria: • Mosquito-Borne Disease: Caused by Plasmodium protozoa and transmitted through the bites of infected female Anopheles mosquitoes. • Life-Threatening: Malaria is life-threatening and caused by Plasmodium parasites. • Disease Progression: Parasites initially multiply in liver cells and then attack red blood cells (RBCs). • Parasite Species: Five parasite species cause malaria in humans, with Plasmodium falciparum and Plasmodium vivax posing the greatest threat.

  7. Global Initiatives: • WHO's 'E-2025 Initiative': Identifies 25 countries with the potential for malaria eradication by 2025. • WHO's Global Technical Strategy: Aims to reduce malaria case incidence and mortality rates significantly by 2030. • High Burden to High Impact (HBHI) Initiative: Launched in high malaria burden countries, including India.

  8. India's Initiatives: • Elimination Target: Government aims to eliminate malaria in India by 2027. • National Framework: Developed a National Framework for Malaria Elimination (2016-2030) and a National Strategic Plan for Malaria Elimination. • Focus on Elimination: Shifting focus from malaria control to elimination. • District-Level Roadmap: Established a roadmap for malaria elimination in 571 out of India's 678 districts by 2022. • MERA-India: The Malaria Elimination Research Alliance-India was formed under the Indian Council of Medical Research (ICMR).

  9. IAS coaching in Karol Bagh • Plutus IAS has received praise for its continued success in offering top-notch and reasonably priced IAS coaching in Karol Bagh Delhi. Our students' everlasting gratitude proves our dedication to developing the next generation of Indian bureaucrats and administrators. • The importance of everyday current affairs cannot be overstated if you wish to succeed in competitive tests like Civil Services. On its website, Plutus IAS includes a separate section for current affairs.

  10. Thank You! For More Information Contact us on Call:- +91 84484-40231 Email:- Info@plutusias.com Visit us:- www.plutusias.com

More Related